David Jeffs - 29 Dec 2023 Form 4 Insider Report for Cell MedX Corp. (STME)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
David Jeffs
Issuer symbol
STME
Transactions as of
29 Dec 2023
Net transactions value
+$622,718
Form type
4
Filing time
10 Jan 2024, 13:10:32 UTC
Previous filing
09 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMXC Common Shares Award $517,718 +73,959,726 $0.007000* 73,959,726 29 Dec 2023 Direct F1
transaction CMXC Common Shares Purchase $52,500 +7,500,000 +10% $0.007000* 81,459,726 29 Dec 2023 Daughter F2
transaction CMXC Common Shares Purchase $52,500 +7,500,000 +9.2% $0.007000* 88,959,726 29 Dec 2023 Son F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Reporting Person acquired 73,959,726 shares on settlement of $517,718 owed by the Issuer to the Reporting Person.
F2 Immediate family members of the Reporting Person acquired a total of 15,000,000 shares on settlement of $105,000 owed by the Issuer to the immediate family members. The inclusion of these shares shall not be deemed an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.